Global Influenza Diagnostics Market Report to 2029: Featuring F. Hoffmann-La Roche, Quidel, Thermo Fisher Scientific, Abbott Laboratories and Hologic Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Nov 7, 2022--

The "Influenza Diagnostics Market Analysis by Test Type (Traditional Diagnostic Tests, Molecular Diagnostic Tests), by End User (Clinical Laboratories, Hospitals), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The global influenza diagnostics market size is estimated to be USD 843.5 million in 2021 and is expected to witness a CAGR of 7.89% during the forecast period.

Companies Mentioned

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Quidel Corporation (U.S.)
• Thermo Fisher Scientific (U.S.)
• Abbott Laboratories (U.S.)
• Hologic (U.S.)
• Becton Dickinson Company (U.S.)
• DiaSorin S.p.A (Italy)
• Luminex Corporation (U.S.)
• Meridian Bioscience (U.S.)
• GenMark Diagnostics (U.S.)

An increase in cases of influenza is a key driver for the growth of the global influenza diagnostics market. Additionally, growing research in the field of influenza and a rise in demand for rapid disease diagnosis in the influenza diagnostics market are some of the other drivers propelling the market growth. Nevertheless, increasing expenditure in healthcare and inconsistency in test sensitivity and specificity in the diagnosis of influenza are expected to restrain the global market growth.

By Test Type

Based on test type, the market is categorized into traditional diagnostic tests, molecular diagnostic tests, and other molecular tests. In 2021, the traditional diagnostic tests segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the increasing adoption of cost-effective and faster diagnostic tests worldwide. The molecular diagnostic segment is anticipated to grow at a profitable CAGR during the forecast period, due to the launch of new products and shift towards molecular diagnostics are the key factors driving the market worldwide.

By End User

Based on end user, the market is categorized into clinical laboratories, hospitals, and other end users. In 2021, the hospitals segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the growing diagnosis of influenza diseases in hospitals worldwide. The clinical laboratories segment is anticipated to grow at a profitable CAGR during the forecast period, due to the high rate of penetration of these laboratories in developed regions.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the strong emphasis of the U.S. CDC on regulating the disease rates, increase in public awareness along with the accessibility of a wide range of diagnostic procedures, and accessibility of technologically advanced products in the region.

Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the adoption of new and developed technologies, increase in awareness among the people, high population mass, and substantial growth in disease burden, are the major factors in this region.

Competitor Insights

The leading players operating in the influenza diagnostics industry are adopting various strategies including R&D investments, adoption of advanced techniques, new product launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The influenza diagnostics market report is categorized into the following segments and subsegments:

Key Topics Covered:

1. Research Methodology

2. Introduction: Influenza Diagnostic

3. Executive Summary

4. Market Dynamics

4.1. Market Drivers

4.2. Market Restraint

4.3. Market Opportunities

4.4. Market Trends

4.5. Market Challenges

5. Market Environment Analysis

5.1. Porter's 5 Forces Analysis

5.2. PESTEL Analysis

5.3. Value Chain Analysis

5.4. SWOT Analysis

5.5. Benchmark

6. COVID-19 Impact Analysis: Influenza Diagnostic Market

7. Market Analysis by Test type

8. Market Analysis by End use

9. Regional Market Analysis

9.1. Regional Market Trends

9.2. Regional Market: Comparative Analysis

10. North America Influenza Diagnostic Market

11. Europe Influenza Diagnostic Market

12. Asia Pacific Influenza Diagnostic Market

13. Latin America Influenza Diagnostic Market

14. MEA Influenza Diagnostic Market

15. Competitor Analysis

16. Company Profiles

17. Conclusion & Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/y8o7ho

View source version on businesswire.com:https://www.businesswire.com/news/home/20221107005785/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: INFECTIOUS DISEASES HEALTH MEDICAL SUPPLIES

SOURCE: Research and Markets

Copyright Business Wire 2022.